There are some challenging things to consider and research for CAR-T:
- The high cost
https://www.webmd.com/cancer/lymphoma/features/navigate-finances-car-t-cell-therapy- Complexity of treatment administration (the greater the complexity, logically the greater the risk, complexity increases cost of trials and so on)
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/car-t-cell-therapy- The saturation of the market (the large number of treatments being developed) makes it hard for new products to secure market share
- Response rates in solid tumours have been limited and there have been significant safety hurdles
https://www.mdpi.com/2072-6694/14/23/5983
General Comments / Chat, page-7522
-
- There are more pages in this discussion • 3,767 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.55 |
Change
-0.020(1.27%) |
Mkt cap ! $264.0M |
Open | High | Low | Value | Volume |
$1.59 | $1.62 | $1.51 | $218.3K | 138.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 95 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.55 | 157 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 95 | 1.525 |
3 | 29100 | 1.500 |
1 | 353 | 1.470 |
2 | 3444 | 1.440 |
3 | 101000 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.550 | 157 | 1 |
1.580 | 6715 | 2 |
1.600 | 2319 | 1 |
1.620 | 5327 | 1 |
1.630 | 1270 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |